Cargando…

Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A.

The effect of 5-fluorouracil (5-FU) on the growth and cellular proliferation of hepatoma 3924A was studied using the following parameters as indices of tumour response: (1) volume measurements, (2) cell kinetic analysis including estimates of both growth and cell loss fractions, (3) changes in tumou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovacs, C. J., Hopkins, H. A., Simon, R. M., Looney, W. B.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1975
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024782/ https://www.ncbi.nlm.nih.gov/pubmed/169869

Ejemplares similares

The modification of labeled cytidine and thymidine incorporation into mitochondrial and nuclear DNA in normal liver, hepatoma 3924A and its host liver by isoproterenol.
por: Chang, L. O., et al.
Publicado: (1969)

Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.
por: Looney, W. B., et al.
Publicado: (1976)

A Preliminary Report on the Thymidine Labeling Indices and Kinetics of Cell Proliferation in Selected Morris Hepatomas
por: Looney, W. B., et al.
Publicado: (1970)

Solid Tumour Models for the Assessment of Different Treatment Modalities: VII: Single vs Fractionated Doses of 5-Fluorouracil on Two Solid Tumours and Their Hosts
por: Looney, W. B., et al.
Publicado: (1978)

Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2
por: Di Blasi, Claudia, et al.
Publicado: (2011)

Combined antitumor effects of P-5m octapeptide and 5-fluorouracil on a murine model of H22 hepatoma ascites
por: Han, Xiao, et al.
Publicado: (2018)

Combined antitumor effects of P-5m octapeptide and 5- fluorouracil on a murine model of H22 hepatoma ascites
por: Han, Xiao, et al.
Publicado: (2019)

LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924
por: Liu, Jinyang, et al.
Publicado: (2020)

Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924
por: Pan, Shutao, et al.
Publicado: (2019)

Rates of incorporation of tritium-labeled thymidine into the mitochondrial and nuclear DNA of normal rat liver, regenerating liver, and four hepatomas with different growth rates and their host livers.
por: Chang, L. O., et al.
Publicado: (1968)

Kinetic Analysis of 5‐Fluorouracil Action against Various Cancer Cells
por: Inaba, Makoto, et al.
Publicado: (1990)

Response kinetics of host and experimental solid tumour after adriamycin.
por: Hopkins, H. A., et al.
Publicado: (1978)

Response and recovery kinetics of a solid tumour after irradiation.
por: Rowley, R., et al.
Publicado: (1980)

An Ideal Approach for Enhancing 5-Fluorouracil Anticancer Efficacy by Nanoemulsion for Cytotoxicity against a Human Hepatoma Cell Line (HepG2 Cells)
por: Mohamed, Jamal Moideen Muthu, et al.
Publicado: (2022)

Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice
por: Cao, Zhiyun, et al.
Publicado: (2015)

CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin
por: Liang, Sheng-ran, et al.
Publicado: (2013)

Responsiveness of enzymes in liver to growth of Novikoff hepatoma.
por: Wu, C., et al.
Publicado: (1969)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
por: Camplejohn, R. S., et al.
Publicado: (1977)

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.
por: Mirjolet, J. F., et al.
Publicado: (1998)

The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
por: Nichols, P. H., et al.
Publicado: (1994)

Effects of SSd Combined with Radiation on Inhibiting SMMC-7721 Hepatoma Cell Growth
por: Wang, Bao-feng, et al.
Publicado: (2014)

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)

Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2023)

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
por: McDermott, B. J., et al.
Publicado: (1983)

Immune effects of 5-fluorouracil: Ambivalence matters
por: Ghiringhelli, François, et al.
Publicado: (2013)

The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth
por: Hu, Xueli, et al.
Publicado: (2020)

Hepatoma-derived growth factor and its role in keloid pathogenesis
por: Ooi, BNS, et al.
Publicado: (2010)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

Inhibitory Effects of (—)‐Epigallocatechin Gallate on Spontaneous Hepatoma in C3H/HeNCrj Mice and Human Hepatoma‐derived PLC/PRF/5 Cells
por: Nishida, Hiroshi, et al.
Publicado: (1994)

Hyperammonemia Secondary to 5-Fluorouracil
por: Scott, Ashley, et al.
Publicado: (2023)

Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis
por: Wang, Wen, et al.
Publicado: (2022)

Characterization of Chitosan-Hybridized Diatomite as Potential Delivery Systems of Oxaliplatin and 5-Fluorouracil Drugs: Equilibrium and Release Kinetics
por: Alfassam, Haifa E., et al.
Publicado: (2023)

Porphyrin Based 2D-MOF Structures as Dual-Kinetic Sorafenib Nanocarriers for Hepatoma Treatment
por: Bieniek, Adam, et al.
Publicado: (2021)

A Comparative Study of the Efficacy of Intralesional 5 Fluorouracil vs Combination of 5 Fluorouracil with Triamcinolone Acetonide in Keloids
por: Monteiro, Rochelle C, et al.
Publicado: (2022)

Growth of massive cementite layers; thermodynamic parameters and kinetics
por: Nikolussi, Marc, et al.
Publicado: (2009)

Predicting Efficacy of 5-Fluorouracil Therapy via a Mathematical Model with Fuzzy Uncertain Parameters
por: Shafiekhani, Sajad, et al.
Publicado: (2022)

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
por: Tamura, Takao, et al.
Publicado: (2011)

In vivo tumour-cell proliferation after adriamycin treatment.
por: Rowley, R., et al.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_jng23gaokqf5kaj8brg0du7atb